Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryuichiro Kanda
Observed name:
R. Kanda
Institution:
University of Occupational and Environmental Health Japan
Observed institutions:
University of Occupational and Environmental Health Japan,
Kitakyushu General Hospital,
Yamaguchi Rosai Hospital
ORCID:
0000-0001-8247-6595
Observed ORCID:
0000-0001-8247-6595
OpenAlex ID:
A5102721713
An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus
2021
·
Maiko Hajime Sumikawa
, Shigeru Iwata
, et al.
·
Rheumatology
·
56
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus
2024
·
Yurie Satoh-Kanda
, Shingo Nakayamada
, et al.
·
RMD Open
·
22
Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD
2022
·
Yasuyuki Todoroki
, Satoshi Kubo
, et al.
·
Rheumatology
·
22
TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus
2022
·
Yu Shan
, Shingo Nakayamada
, et al.
·
Rheumatology
·
21
Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease
2022
·
Satoshi Kubo
, Ryuichiro Kanda
, et al.
·
RMD Open
·
18
PDF
mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors
2021
·
Mingzeng Zhang
, Shigeru Iwata
, et al.
·
Rheumatology
·
13
Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry
2025
·
Ryuichiro Kanda
, Yusuke Miyazaki
, et al.
·
Rheumatology and Therapy
·
10
Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis
2021
·
Shigeru Iwata
, Mingzeng Zhang
, et al.
·
Rheumatology
·
10
Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus
2024
·
Masanobu Ueno
, Shigeru Iwata
, et al.
·
RMD Open
·
9
PDF
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study
2023
·
Koshiro Sonomoto
, Shingo Nakayamada
, et al.
·
Rheumatology
·
9
Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry
2023
·
Satoshi Kubo
, Yusuke Miyazaki
, et al.
·
Rheumatology and Therapy
·
9
PDF
A case of bone destruction caused by chronic non-bacterial osteomyelitis (CNO) successfully repaired with a tumour necrosis factor-α (TNF-α) inhibitor, adalimumab
2020
·
Ryuichiro Kanda
, Kazuhisa Nakano
, et al.
·
Modern Rheumatology Case Reports
·
9
A case of eosinophilic granulomatosis with polyangiitis as a mimicker of IgG4-related disease
2020
·
Ryuichiro Kanda
, Satoshi Kubo
, et al.
·
Modern Rheumatology Case Reports
·
7
Association of exercise-induced pulmonary hypertension with nailfold capillary density in systemic sclerosis: a single-center retrospective observational study
2025
·
Katsuhide Kusaka
, Satoshi Kubo
, et al.
·
Arthritis Research & Therapy
·
4
PDF
Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs Do Not Arrest Bone Loss in Patients With Rheumatoid Arthritis: A Long‐Term Multicenter Observational Study
2026
·
Takafumi Aritomi
, Koshiro Sonomoto
, et al.
·
Arthritis & Rheumatology
·
3
Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registry
2026
·
Hidenori Sakai
, Koshiro Sonomoto
, et al.
·
RMD Open
·
2
Short-chain fatty acid deficiency drives aberrant B cell differentiation in systemic lupus erythematosus
2026
·
Ryuichiro Kanda
, Satoshi Kubo
, et al.
·
Clinical Immunology
·
1
Op0306 Effectiveness of Rituximab and Tocilizumab in Managing Skin Fibrosis in Patients With Systemic Sclerosis
2024
·
S. Kubo
, Y. Satoh-Kanda
, et al.
·
Annals of the Rheumatic Diseases
·
1
Remission of Granulomatosis with Polyangiitis Only After Resection of a Pulmonary Nodule
2022
·
Ryuichiro Kanda
, Kazuhisa Nakano
, et al.
·
Internal Medicine
·
1
PDF
Effectiveness of Anifrolumab in Patients with Systemic Lupus Erythematosus Who Did Not Achieve LLDAS: Findings from the LOOPS Registry
2026
·
Satsuki Matsunaga
, Satoshi Kubo
, et al.
·
Research Square
PDF
Treatment persistence and clinical outcomes following subcutaneous methotrexate initiation in patients with rheumatoid arthritis: A real-world observational study
2026
·
Yusuke Miyazaki
, Satoshi Kubo
, et al.
·
Modern Rheumatology
Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis
2026
·
Ryuichiro Kanda
, Yoshiya Tanaka
, et al.
·
Rheumatology
Clinical and immunological outcomes of rituximab-based, mycophenolate mofetil-based and cyclophosphamide-based treatment strategies for systemic lupus erythematosus with active kidney involvement from LOOPS registry
2026
·
Masanobu Ueno
, Ippei Miyagawa
, et al.
·
RMD Open
PDF
Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry
2026
·
Satoshi Kubo
, Yoshiya Tanaka
, et al.
·
RMD Open
Effectiveness and safety of sarilumab in polymyalgia rheumatica: A retrospective study of the FIRST registry
2026
·
Naoaki Ohkubo
, Yusuke Miyazaki
, et al.
·
Modern Rheumatology
Show more works
View as search
Works count:
26
Citation count:
227
H-index:
9
I10-index:
8
Year
Topic
Type